ROVI — Laboratorios Farmaceuticos Rovi SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousLarge CapHigh Flyer

Market Cap
€4.40bn
Enterprise Value
€4.45bn
Revenue
€829.51m

Annual balance sheet for Laboratorios Farmaceuticos Rovi SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	67.4	53.2	99	125	25.3
Net Total Accounts Receivable
Net Total Receivables	91.6	84.2	160	184	143
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	318	365	506	623	509
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	132	155	182	216	254
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	511	574	733	879	800
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	107	123	190	294	200
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	189	201	262	359	260
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Total Equity	322	374	471	520	539
Total Liabilities & Shareholders' Equity	511	574	733	879	800
Total Common Shares Outstanding